DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Conditions:   Hematopoietic and Lymphoid Cell Neoplasm;   Recurrent Acute Lymphoblastic Leukemia;   Recurrent Acute Myeloid Leukemia;   Recurrent Chronic Myelomonocytic Leukemia;   Recurrent Myelodysplastic Syndrome;   Refractory Acute Lymphoblastic Leukemia;   Refractory Acute Myelo id Leukemia;   Refractory Chronic Myelomonocytic Leukemia;   Refractory Myelodysplastic Syndrome Interventions:   Biological: Antineoplastic Antibody-Drug Conjugate;   Drug: Azacitidine;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone;   Biological: Filgrastim;   Drug: Leucovo...
Source: ClinicalTrials.gov - February 12, 2021 Category: Research Source Type: clinical trials

A Study of a New Way to Treat Children With a Brain Tumor Called NGGCT
Conditions:   Central Nervous System Nongerminomatous Germ Cell Tumor;   Embryonal Carcinoma;   Immature Teratoma;   Malignant Teratoma;   Mixed Germ Cell Tumor;   Pineal Region Germ Cell Tumor;   Pineal Region Immature Teratoma;   Pineal Region Yolk Sac Tumor Interventions:   Drug: Carboplatin;   Drug: Etoposide;   Biological: Filgrastim;   Drug: Ifosfamide;   Drug: Mesna;   Biological: Pegfilgrastim;   Procedure: Peripheral Blood Stem Cell Transplantation;   Other: Questionnaire Administration;   Radiation: Radiation Therapy;   Drug: Thiotepa Sponsor:   Children's OncologyÂ...
Source: ClinicalTrials.gov - December 24, 2020 Category: Research Source Type: clinical trials